FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

NDMA Testing on Ranitidine Better Than First Thought: FDA

An FDA update on an ongoing investigation about a contaminant known as N-Nitrosodimethylamine found in ranitidine (Zantac) says that preliminary testi...

Medical Devices

Xact Robotics Percutaneous Interventional Device Cleared

FDA clears an Xact Robotics 510(k) for its robotic system and its use during computed tomography guided percutaneous interventional procedures.

Medical Devices

Thoratec Recalls CentriMag Systems

Thoratec Switzerland recalls its CentriMag Acute Circulatory Support System Motor, which is a component of the CentriMag Extracorporeal Blood Pumping ...

Federal Register

Mexitil Not Withdrawn Over Safety/Efficacy: FDA

Federal Register notice: FDA determines that Boehringer Ingelheims Mexitil (mexiletine hydrochloride) was not withdrawn from sale for safety or effect...

Medical Devices

Stryker Sahara Lateral 3D Spine Implant Cleared

FDA clears a Stryker 510(k) for its Sahara Lateral 3D Expandable Interbody System featuring Lamellar 3D Titanium Technology.

Medical Devices

Senators Have More Software Pre-Cert Questions

Sens. Warren, Murray, and Smith raise 18 additional questions for FDA to answer on its software pre-certification program.

Human Drugs

GDUFA 2 User Fee Assessment

FDA issues a draft guidance on changes affecting its implementation of GDUFA 2 user fees.

Biologics

Genentech BLA Submitted for Satralizumab

FDA accepts for review a Genentech BLA for satralizumab for treating adults and adolescents with neuromyelitis optica spectrum disorder.

Human Drugs

Developing Drugs for Hepatitis D Virus Infection

FDA publishes a draft guidance to assist sponsors develop drugs to treat hepatitis D virus infection.

Federal Register

Meeting on Health Equity Related to Opioid Crisis

Federal Register notice: FDA announces an 11/21 public meeting entitled Office of Minority Health and Health Equity Public Meeting on Strategies to Im...